TYLER GREEN: Open Payments
NPI 1700217494 · DAYTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,873 in 81 payments from 15 companies in 2025. Trend: 2023 $1,328 · 2024 $1,925 · 2025 $1,873
Food & beverage: $1,762Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 22 | $623 |
| Vanda Pharmaceuticals Inc. | 12 | $341 |
| Otsuka America Pharmaceutical, Inc. | 11 | $144 |
| Axsome Therapeutics, Inc. | 1 | $122 |
| Alkermes, Inc. | 5 | $96 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $85 |
| Lundbeck LLC | 4 | $80 |
| Neurocrine BioSciences, Inc. | 3 | $66 |
| Biogen, Inc. | 3 | $57 |
| ABBVIE INC. | 3 | $56 |
Products named: AUSTEDO XR, UZEDY, REXULTI, HETLIOZ, FANAPT, Auvelity, ARISTADA, TRINTELLIX.
Industry payments across OH — which companies pay providers there.
